Treatment for osteoporosis in people with ß-thalassaemia-Reference-Cited by-同舟云学术

Treatment for osteoporosis in people with ß-thalassaemia

Published:2016-03-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bhardwaj Amit¹,Swe Kye Mon Min²,Sinha Nirmal K³,Osunkwo Ifeyinwa⁴

Affiliation:

1. Newcastle University Medicine Malaysia, No 1; Jalan Sarjana 1 Kota Ilmu, Educity@iskandar Nusajaya Johor Malaysia 79200

2. Perdana University, Royal College of Surgeons in Ireland School of Medicine (PU-RCSI); Blok D, Level 1, MAEPS Building, MARDI Complex, Jalan MAEPS Perdana Serdang Selangor Darul Ehsan Malaysia 43400

3. Melaka-Manipal Medical College (MMMC); Department of Orthopaedics; Jalan Batu Hampar Bukit Baru Melaka Melaka Malaysia 75150

4. Aflac Cancer and Blood Disorders Service, Emory University School of Medicine; Comprehensive Sickle Cell Program; 1405 Clifton Road, NE Atlanta Georgia USA GA 30322

Publisher

Wiley

Subject

Pharmacology (medical)

Reference69 articles.

1. Neridronate (NE) for the treatment of osteoporosis in patients with beta-thalassemia: results from an Italian multicenter randomized, open label, phase II trial [abstract];Forni;Blood,2010

2. Neridronate improves bone mineral density and reduces back pain in beta-thalassaemia patients with osteoporosis: results from a phase 2, randomized parallel-arm, open-label study;Forni;British Journal of Haematology,2012

3. Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial;Fung;American Journal of Clinical Nutrition,2013

4. Bisphosphonates in the treatment of thalassemia-induced osteoporosis;Morabito;Osteoporosis International,2002

5. Effect of pamidronate on bone remodeling in adult patients with beta-thalassemia major and osteoporosis [abstract];Voskaridou;Bone,2003

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives;Frontiers in Immunology;2024-08-05

2. Zoledronic acid: challenges and pitfalls amid rehabilitation in primary osteoporosis and beyond;Balneo and PRM Research Journal;2024-06-21

3. Bone Health Impairment in Patients with Hemoglobinopathies: From Biological Bases to New Possible Therapeutic Strategies;International Journal of Molecular Sciences;2024-03-01

4. Review of endocrine complications in transfusion-dependent thalassemia;Iranian Journal of Blood and Cancer;2023-09-01

5. Treatment for osteoporosis in people with beta-thalassaemia;Cochrane Database of Systematic Reviews;2023-05-09